Trial Profile
A Phase 2, Gender-Stratified, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of a Two Vaccination Regimen With the Travelers' Diarrhea Vaccine System in Healthy Adults.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Feb 2020
Price :
$35
*
At a glance
- Drugs Heat-labile enterotoxin E coli (Primary)
- Indications Enterotoxigenic Escherichia coli infections; Traveller's diarrhoea
- Focus Adverse reactions
- Sponsors Intercell USA; Valneva USA
- 11 Dec 2017 According to a Valneva media release, Intercell USA changed its name to Valneva USA.
- 08 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Mar 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.